about
Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).Summarizing historical information on controls in clinical trialsThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes riskDesign and Measurement of Nonislet-Specific Autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody WorkshopGenetics of type 1 diabetes: what's next?Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations.Imputation of orofacial clefting data identifies novel risk loci and sheds light on the genetic background of cleft lip ± cleft palate and cleft palate only.Interpretation of custom designed Illumina genotype cluster plots for targeted association studies and next-generation sequence validation.The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes.Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium.Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesisAssociation analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci.Non-random mating, parent-of-origin, and maternal-fetal incompatibility effects in schizophrenia.Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHCHaplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease.The HLA-B 3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes.Dominant suppression of Addison's disease associated with HLA-B15A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysisCongruence as a measurement of extended haplotype structure across the genome.Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis.Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexRecursive organizer (ROR): an analytic framework for sequence-based association analysis.Immunogenetics of spontaneous control of HIVImmunochip analysis identifies multiple susceptibility loci for systemic sclerosis.Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.The past, present, and future of genetic associations in type 1 diabetes.Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseasesEffects of the genome on immune regulation in type 1 diabetes.New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.A unified framework for haplotype inference in nuclear families.First-Class Control of HIV-1Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicityHIV immunity is all in the amino acids
P2860
Q28749882-AD50657A-5300-464D-996F-4F2555D82162Q29397593-86F922E0-7452-43CC-9298-081F1746AC68Q29417018-A0E8BE91-1E30-43B4-A791-7032DC8820ECQ30279028-2DCAECFA-A1B6-4B52-845B-4ABADC2AC90AQ30356194-786BD39A-7332-4949-A954-F6FE4418504EQ30431554-DB4FE205-09DF-4BB8-A2E6-B933E0F86245Q30793085-AA28F217-F7CE-4F8A-9E08-76D6F05D7962Q31154691-9AD7B09E-D371-47D2-A7DB-8FCA9BCB9AD2Q33533461-E282383D-D9D0-403F-9AA4-DD2C5EAD6825Q33539771-C09DD5C0-E206-469F-B0DF-55019E41E5B4Q33804973-B5A4F4D8-452B-4F19-B637-976C3D43913EQ34051595-5C1147E1-4EC1-48EF-8374-D4EC68C4C428Q34250412-1ECACA79-159D-4656-A939-752D6BC029B8Q34259926-E5C0A550-38E1-409E-9B12-3AF7C02C0751Q34277534-5F67B69B-B338-41BE-8CD8-E968BD1BE936Q34341022-A2267EA8-C0C8-49C9-B8D2-BDBA587F0825Q34486702-BC277CDD-82A7-4821-974C-E5C03687325BQ34630650-0F1649D3-FF27-4F31-891D-3AFBDA3F0A93Q35031671-5CFB9D24-D624-492D-9167-5C7064455021Q35101847-59E46721-63E8-4F95-8459-28E7A8FB9DA9Q35266391-E79E1C60-A60C-442D-BDD2-9F2E2F3CB4ABQ35563220-179CB11F-5581-47A6-AC0A-FB836B34F66FQ35754787-BD43AB66-1BE5-4B3D-A317-BBEE07B1D542Q35847732-D3A33629-0071-488D-84DC-19BB48A0A51EQ35927065-C7F60438-0B29-4423-A79F-AF457497394DQ36109098-064B389C-D469-447C-89C3-63DB4DA0AC38Q36722514-A6542958-5821-4F01-85C7-4EEF2B595961Q36931170-A6544D08-06D2-4B94-9FCE-203A569EA4DCQ37051202-E8A90B71-50E7-4368-B231-2C075D083328Q37441841-CEB94668-D012-47B4-A71E-F711E1159A0EQ37693227-F057F477-F940-4BFE-A881-6EFE5D6B0B8AQ37906351-C87CC857-5A18-4E3E-82A9-4C6A25255E2AQ39080731-417EB295-25E9-49F8-9494-D487D6C118AFQ39605597-437AB64B-1DF6-454A-A43C-552C924B2379Q40546678-DCC279AE-591D-4883-B264-5F127174A73FQ42155343-E4C302EF-675F-47A6-ABD2-1D676B4956BEQ51366697-0B2711B8-0EAA-4833-8F2A-09E291BA0A1FQ56914147-D4F79CFD-F7EF-472D-BA3D-BFA3E413BB68Q58351991-29C511E7-07B5-4D80-9F3C-6065A8C54362Q59038871-8960F389-030B-493B-951F-A073A7F1950B
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Overview of the MHC fine mapping data.
@ast
Overview of the MHC fine mapping data.
@en
type
label
Overview of the MHC fine mapping data.
@ast
Overview of the MHC fine mapping data.
@en
prefLabel
Overview of the MHC fine mapping data.
@ast
Overview of the MHC fine mapping data.
@en
P2093
P2860
P1476
Overview of the MHC fine mapping data.
@en
P2093
J C Mychaleckyj
J E Hilner
L H Perdue
R B Venkatesh
Type 1 Diabetes Genetics Consortium
P2860
P356
10.1111/J.1463-1326.2008.00997.X
P478
11 Suppl 1
P577
2009-02-01T00:00:00Z